Home › Medulloblastoma › Illinois › Chicago
Medulloblastoma clinical trials in Chicago, IL
3 studies for Medulloblastoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RecruitingPhase 3
- University of Illinois, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
RecruitingPhase 2
- Advocate Aurora Research Institute, Chicago
Medulloblastoma trials in other cities
- Washington, DC9 studies
- St. Louis, MO6 studies
- Houston, TX4 studies
- New York City, NY4 studies
- Philadelphia, PA4 studies
- Miami, FL4 studies
- Seattle, WA4 studies
- Durham, NC4 studies
- Tampa, FL4 studies
- Memphis, TN3 studies
- Columbus, OH3 studies
- Ann Arbor, MI3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.